JAK-Inhibitors – A Story of Success and Adverse Events

Rebekka Wlassits1 Karl Landsteiner Institut für Autoimmunerkrankungen und Rheumatologie, Vienna, AustriaCorrespondence[email protected]
View further author information

Mathias Müller2 Department für Biomedizinische Wissenschaften, Institut für Tierzucht und Genetik, Veterinärmedizinische Universität Wien, Vienna, AustriaView further author information

Karl H Fenzl1 Karl Landsteiner Institut für Autoimmunerkrankungen und Rheumatologie, Vienna, AustriaView further author information

Thomas Lamprecht3 Ludwig Erlacher, Karl Landsteiner Institut für Autoimmunerkrankungen und Rheumatologie, Vienna, AustriaView further author information

Ludwig Erlacher3 Ludwig Erlacher, Karl Landsteiner Institut für Autoimmunerkrankungen und Rheumatologie, Vienna, AustriaView further author information

JAK-Inhibitors – A Story of Success and Adverse Events

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

JAK-Inhibitors – A Story of Success and Adverse Events

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date